Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Scotland's gluten-free pilot attracts almost 100 per cent of pharmacies

More than 99 per cent take up of scheme is 'encouraging' says Community Pharmacy Scotland


EXCLUSIVE

More than 99 per cent of Scottish contractors have signed up for a pilot gluten-free dispensing service, C+D has learned.


Only six of the 1,250 pharmacies in the country had opted out of the scheme, which showed the "willingness of the pharmacy network to engage" with the care of coeliac patients, Community Pharmacy Scotland (CPS) told C+D on Friday (May 16).


The high uptake for the year-long pilot, which launched last month, was an "encouraging sign" and CPS had already asked the Scottish government to find a way for the gluten-free prescriptions to be recorded electronically if the pilot proved successful, said CPS pharmacy services manager Matt Barclay.


The service, for which contractors are paid £125 a month through Scotland's pharmacy contract, enables adult and paediatric patients diagnosed with coeliac disease or dermatitis herpetiformis to request individual gluten-free items from a pharmacist, rather than visiting their GP for a prescription.


The pilot will be evaluated against patient satisfaction, cost-effectiveness and collaboration between healthcare professionals.


Contractors are paid £125 per month for the service through Scotland's pharmacy contract

More on pharmacy in Scotland

Scottish pilot could inluence UK rollout of gluten-free dispensing service

NHS Scotland campaign gets patients talking about their medicine

Scotland's pharmacists to take over monitoring patients on high-risk medicines



Mr Barclay said transferring patients across from GP care would be a "gradual process" and pharmacists had reported a "trickle" of patients entering the scheme so far.


Samantha Melrose, director of the Buchanhaven Pharmacy group in Aberdeenshire, said there was no reason why pharmacists would opt out of the service.


"It's quite an easy service to deliver and patients really like it. We can give them a lot more advice when choosing products," she told C+D.


But Ms Melrose said she was concerned GPs were continuing to prescribe larger quantities of gluten-free products to some patients than they were entitled to, which reflected badly on pharmacists who dispensed the correct amount.


"It looks like pharmacy is trying to restrict how much patients get, [when] it should be restricted everywhere. We've heard horror stories about patients getting 10 times [their allocation] from their GP," she added.


Last year, CPS said the pilot would produce data on the benefits of pharmacist interventions with coeliac patients and demonstrate why the service could be rolled out in England and Wales.

Would gluten-free dispensing benefit your patients?
 
We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD017009

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel